Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › HI › Wailuku › NPI 1013379460
Hospital

Maui Health System a Kaiser Foundation Hospitals LLC

Maui Health System a Kaiser Foundation Hospitals LLC was paid $60.37M by Medicaid between Jan 2018 and Dec 2024, across 239 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.

33Billing provider infoMAUI HEALTH SYSTEM A KAISER FOUNDATION HOSPITALS LLC
WAILUKU, HI 96793
33aNPI1013379460assigned 03/24/2016
33bProvider typeGeneral Acute Care Hospital
28Total paid$60.37M
24GClaims711,261
24DCodes billed239
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Hawaii

Rank by total paid#2 of 18
Median peer was paid$10.94M
This provider vs. median5.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018115,389$9.96M
2019111,326$9.28M
202071,626$5.83M
202196,127$7.17M
2022107,560$8.36M
2023110,075$9.43M
2024incomplete99,158$10.33M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 35% 40,669 35,915 $21.15M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 23,462 20,265 $14.06M
74177 Computed tomography, abdomen and pelvis; with contrast material 9.9% 5,731 5,205 $5.98M
99282 Emergency department visit for the evaluation and management, low to moderate severity 8.4% 14,578 13,405 $5.10M
G0378 Hospital observation service, per hour 5.6% 3,249 2,605 $3.39M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.6% 3,688 3,278 $2.77M
74176 Computed tomography, abdomen and pelvis; without contrast material 3.4% 2,180 2,034 $2.03M
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.3% 5,515 5,126 $1.40M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 7,085 5,926 $886K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.0% 17,433 11,542 $625K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 430 386 $549K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 3,291 1,789 $281K
227 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 11,365 $256K
96361 Intravenous infusion, hydration; each additional hour <1% 9,238 $256K
70450 Computed tomography, head or brain; without contrast material <1% 6,442 $205K
59025 Fetal non-stress test <1% 669 $159K
71275 Computed tomographic angiography, chest, with contrast material <1% 851 $146K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,291 $103K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16,013 $96K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,407 $89K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 864 $85K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 620 $80K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 532 $73K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,173 $56K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 19,097 $46K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,623 $33K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 6,463 $30K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 11,038 $29K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 955 $26K
73610 <1% 1,469 $26K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 888 $24K
96375 Therapeutic injection; each additional sequential IV push <1% 16,684 $23K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 754 $18K
72125 Computed tomography, cervical spine; without contrast material <1% 2,074 $16K
86900 <1% 3,046 $15K
80053 Comprehensive metabolic panel <1% 14,791 $15K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 57 $15K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,179 $14K
71046 Radiologic examination, chest; 2 views <1% 1,962 $12K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,782 $10K
70486 <1% 268 $9K
73130 <1% 927 $8K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,692 $8K
36430 <1% 53 $7K
84443 Thyroid stimulating hormone (TSH) <1% 2,859 $7K
12001 <1% 544 $7K
73030 <1% 933 $6K
12011 <1% 180 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 34,956 $5K
96367 <1% 1,913 $5K
71045 Radiologic examination, chest; single view <1% 13,369 $5K
73110 <1% 562 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,171 $5K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 68 $4K
41899 Unlisted procedure, dentoalveolar structures <1% 83 $4K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,501 $4K
10061 <1% 30 $4K
80048 Basic metabolic panel (calcium, ionized) <1% 17,256 $3K
12002 <1% 170 $3K
99152 <1% 539 $3K
83880 <1% 3,807 $3K
73630 <1% 1,286 $3K
91320 <1% 13 $3K
99214 Doctor's office visit, returning patient (more involved) <1% 55 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 16 $3K
96160 <1% 2,492 $3K
93971 <1% 270 $2K
73080 <1% 174 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 278 $2K
80320 <1% 548 $2K
85027 <1% 4,395 $2K
73562 <1% 732 $2K
84703 <1% 9,261 $2K
97161 <1% 110 $2K
73590 <1% 89 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 629 $2K
20610 <1% 14 $2K
87186 <1% 3,155 $2K
84484 <1% 10,720 $2K
83690 <1% 10,880 $1K
70496 <1% 37 $1K
72100 <1% 208 $1K
76830 Ultrasound, transvaginal <1% 143 $1K
73564 <1% 33 $1K
80076 <1% 8,056 $1K
81001 <1% 16,504 $1K
76801 <1% 525 $1K
82803 <1% 3,037 $1K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 72 $1K
99308 Subsequent nursing facility care, per day, straightforward <1% 50 $1K
J7030 Infusion, normal saline solution , 1000 cc <1% 31,787 $1K
80047 <1% 9,762 $1K
0001A <1% 63 $1K
70498 <1% 51 $1K
73090 <1% 64 $982.90
96523 <1% 61 $938.99
70551 Magnetic resonance imaging, brain; without contrast material <1% 24 $858.00
83605 <1% 4,951 $832.00
87040 <1% 5,327 $787.76
90715 <1% 1,006 $762.55
73502 <1% 137 $751.94
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,269 $686.34
85610 <1% 6,789 $675.76
85730 <1% 4,895 $623.77
0450 Emergency room services <1% 14 $587.34
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 3,548 $562.86
84702 <1% 1,443 $541.51
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 14,551 $513.97
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,864 $472.26
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 6,731 $417.74
97165 <1% 16 $408.82
J1170 Injection, hydromorphone, up to 4 mg <1% 6,674 $385.70
96376 <1% 4,326 $383.10
81003 <1% 7,177 $374.25
29125 <1% 68 $369.08
J3490 Unclassified drugs <1% 8,082 $364.28
85379 <1% 1,419 $358.86
87077 <1% 3,075 $338.77
83735 <1% 4,881 $338.32
87070 <1% 864 $336.98
82962 <1% 2,657 $325.06
99204 Doctor's office visit, new patient (more involved) <1% 32 $320.93
99153 Mod sedat endo service >5yrs <1% 116 $312.90
73140 <1% 41 $273.55
P9016 Red blood cells, leukocytes reduced, each unit <1% 34 $268.74
73070 <1% 13 $254.41
86920 <1% 56 $239.50
36415 Collection of venous blood by venipuncture <1% 15,672 $226.54
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,418 $222.19
73100 <1% 22 $220.18
82330 <1% 1,000 $214.06
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,619 $204.24
86850 <1% 2,549 $201.22
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 263 $196.22
86140 <1% 2,511 $176.30
86901 <1% 3,054 $161.53
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 27 $153.55
J2060 Injection, lorazepam, 2 mg <1% 4,031 $147.27
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,218 $147.16
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,838 $147.11
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 15 $141.54
85014 <1% 2,720 $138.83
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 388 $137.17
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,545 $136.95
80069 <1% 25 $136.66
74018 <1% 71 $133.10
82947 <1% 3,670 $132.37
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,421 $115.32
J2704 Injection, propofol, 10 mg <1% 5,740 $113.65
84145 <1% 457 $98.79
85018 <1% 2,583 $90.36
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,938 $73.35
84100 <1% 999 $73.27
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,992 $63.34
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 10,800 $61.78
82550 <1% 24 $55.89
J3480 Injection, potassium chloride, per 2 meq <1% 367 $47.82
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 684 $40.52
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,088 $38.20
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 260 $36.80
84460 <1% 638 $32.83
87088 <1% 451 $32.82
84450 <1% 651 $32.32
A9270 Non-covered item or service <1% 789 $30.76
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,924 $29.03
82247 <1% 439 $27.40
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,894 $27.05
J3370 Injection, vancomycin hcl, 500 mg <1% 493 $26.93
96368 <1% 451 $22.78
97116 <1% 22 $21.80
96161 <1% 531 $21.70
C1769 Guide wire <1% 393 $21.35
82565 <1% 870 $19.62
84075 <1% 361 $19.40
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 22 $19.19
J0690 Injection, cefazolin sodium, 500 mg <1% 3,422 $18.28
80051 <1% 414 $18.27
J2550 Injection, promethazine hcl, up to 50 mg <1% 973 $17.71
84439 <1% 51 $16.97
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 648 $16.26
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 460 $16.11
J1790 Injection, droperidol, up to 5 mg <1% 93 $14.33
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 389 $11.22
J1815 Injection, insulin, per 5 units <1% 325 $7.86
J1644 Injection, heparin sodium, per 1000 units <1% 1,991 $5.81
87081 <1% 62 $5.68
J1171 Injection, hydromorphone, 0.1 mg <1% 192 $5.49
J3360 Injection, diazepam, up to 5 mg <1% 562 $5.30
84520 <1% 430 $4.44
J0360 Injection, hydralazine hcl, up to 20 mg <1% 478 $3.40
C1757 Catheter, thrombectomy/embolectomy <1% 2,190 $2.82
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,612 $1.00
J1630 Injection, haloperidol, up to 5 mg 0% 544 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 191 $0.00
90480 0% 13 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 58 $0.00
88304 0% 234 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 251 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 15 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 351 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 314 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 571 $0.00
83036 Hemoglobin; glycosylated (A1C) 0% 138 $0.00
J2469 Injection, palonosetron hcl, 25 mcg 0% 148 $0.00
3074F 0% 16 $0.00
J7042 5% dextrose/normal saline (500 ml = 1 unit) 0% 93 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 0% 69 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 0% 208 $0.00
80329 0% 75 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 20 $0.00
71101 0% 27 $0.00
90656 0% 16 $0.00
86141 0% 24 $0.00
90686 0% 52 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 27 $0.00
94762 0% 17 $0.00
85651 0% 14 $0.00
99151 0% 15 $0.00
A4565 Slings 0% 14 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 228 $0.00
82570 0% 164 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 34 $0.00
10060 0% 91 $0.00
90749 0% 87 $0.00
C1758 Catheter, ureteral 0% 25 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 316 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 50 $0.00
84156 0% 32 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 47 $0.00
1159F 0% 17 $0.00
80061 Lipid panel 0% 17 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 75 $0.00
93017 0% 16 $0.00
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 0% 21 $0.00
76000 0% 56 $0.00
J7510 Prednisolone oral, per 5 mg 0% 12 $0.00
3078F 0% 17 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 19 $0.00
J0878 Injection, daptomycin, 1 mg 0% 23 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCARTWRIGHT, DEBRA (CFO)